Holen Sie sich die Stockscreener-App
19.23
0.44%
-0.085
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt KVUE?
Forum
Prognose
Dividendenhistorie
Kenvue Inc Aktie (KVUE) Neueste Nachrichten
Maverick Capital Ltd. Buys Shares of 92,009 Kenvue Inc. $KVUE - MarketBeat
Polar Asset Management Partners Inc. Lowers Position in Kenvue Inc. $KVUE - MarketBeat
Lazard Asset Management LLC Trims Stock Position in Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc (KVUE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Kenvue Inc (KVUE) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Kenvue Inc. stock rises Monday, outperforms market - MarketWatch
Kenvue Inc (KVUE) Balance Sheet - TradingKey
Renaissance Technologies LLC Purchases New Position in Kenvue Inc. $KVUE - MarketBeat
Morningstar Investment Management LLC Trims Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
First Trust Advisors LP Has $49.81 Million Holdings in Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc. $KVUE Shares Acquired by Gabelli Funds LLC - MarketBeat
Kenvue, Inc. Revenue Breakdown – DUS:J4D - TradingView
Healthcare of Ontario Pension Plan Trust Fund Has $62.17 Million Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
Absolute Gestao de Investimentos Ltda. Takes Position in Kenvue Inc. $KVUE - MarketBeat
Kenvue stock holds steady after latest earnings and outlook - AD HOC NEWS
Tylenol With Naproxen FDA Approval Could Be A Game Changer For Kenvue (KVUE) - Yahoo Finance
Kenvue (KVUE) Gets An FDA Lift On Tylenol As Valuation Looks Tight - Yahoo Finance UK
Naproxen-Powered Pain Relief Medications: Kenvue Receives FDA Approval for TYLENOL… - Trend Hunter
Jim Cramer Says Kimberly-Clark’s Acquisition of Kenvue Creates a High-Margin Powerhouse - Yahoo Finance
5,211,114 Shares in Kenvue Inc. $KVUE Acquired by Kryger Capital LLC - MarketBeat
GABELLI & Co INVESTMENT ADVISERS INC. Raises Holdings in Kenvue Inc. $KVUE - MarketBeat
Bank of Nova Scotia Acquires 816,428 Shares of Kenvue Inc. $KVUE - MarketBeat
Kenvue, Inc. Revenue Breakdown – FWB:J4D - TradingView
Kenvue, Inc. (KVUE) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks
US FDA approves over-the-counter Tylenol combination pill for pain relief - Reuters
Kenvue Inc. stock rises Friday, outperforms market - MarketWatch
Kenvue Inc (KVUE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Kenvue Inc (KVUE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Kenvue Inc (KVUE) Valuation: PE, PB & Fair Value Analysis - TradingKey
Kenvue Says FDA Has Granted Tylenol Three-Year Exclusivity For New OTC Formulation - TradingView
FDA approves Tylenol® with Naproxen, the first and only over-the-counter fixed-dose combination of acetaminophen (650 mg) and naproxen sodium (220 mg) - Kenvue
Kenvue Inc (KVUE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Does Illinois Talc Verdict Successor Liability Ruling Change The Bull Case For Kenvue (KVUE)? - simplywall.st
Kenvue Inc (KVUE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
This "Boring" Dividend King Is Quietly Turning Into a Growth Machine -- and Many Investors Are Missing It - The Motley Fool
Kenvue Inc (KVUE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
KVUE|Kenvue Inc|Price:19.477|Chg%:+0.197 - TradingKey
Mizuho Markets Americas LLC Trims Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
Listerine Cool Mint by Kenvuemouthwash classic boosts oral care sales - Ad-hoc-news.de
Capula Management Ltd Grows Position in Kenvue Inc. $KVUE - MarketBeat
Caxton Associates LLP Makes New Investment in Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc. stock falls Thursday, still outperforms market - MarketWatch
Kenvue to announce Q2 2026 results on August 6, 2026 - scanx.trade
Press Release: Kenvue to Announce Second Quarter 2026 Results on August 6, 2026 - 富途牛牛
Kenvue to Announce Second Quarter 2026 Results on August 6, 2026 - The Joplin Globe
Levin Capital Strategies L.P. Raises Stake in Kenvue Inc. $KVUE - MarketBeat
Technical Reactions to KVUE Trends in Macro Strategies - Stock Traders Daily
Kenvue Inc. (NYSE:KVUE) Given Average Rating of "Hold" by Analysts - MarketBeat
Kenvue broadens China focus on minor ailment management - China Daily Global Edition
What to expect from Kenvue’s Q2 2026 earnings report - MSN
KBC Group NV Increases Holdings in Kenvue Inc. $KVUE - MarketBeat
SEB Asset Management AB Purchases New Position in Kenvue Inc. $KVUE - MarketBeat
Dimensional Fund Advisors LP Has $383.94 Million Position in Kenvue Inc. $KVUE - MarketBeat
The Listerine Cool Mint MouthwashKenvue bets on bold flavor and plaque control - Ad-hoc-news.de
Kenvue stock steadies as consumer health margins lift earnings outlook - Ad-hoc-news.de
Barclays Adjusts Price Target on Kenvue to $19 From $18, Maintains Equalweight Rating - marketscreener.com
What to Expect From Kenvue’s Q2 2026 Earnings Report - Barchart.com
Kenvue Inc. $KVUE Shares Sold by Kapitalo Investimentos Ltda - MarketBeat
Swiss National Bank Has $96.94 Million Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
Kenvue stock trades steadily as consumer health spin-off builds earnings record - Ad-hoc-news.de
Kenvue Inc. (KVUE) Stock Price | Live Quotes & Charts | NYSE - timothysykes.com
Kenvue Inc. $KVUE Stake Lifted by Hsbc Holdings PLC - MarketBeat
California Public Employees Retirement System Decreases Stake in Kenvue Inc. $KVUE - MarketBeat
Kenvue stock holds steady as the latest report frames 2026 margins - Ad-hoc-news.de
Bank of New York Mellon Corp Sells 223,497 Shares of Kenvue Inc. $KVUE - MarketBeat
Kenvue stock trades steadily as consumer health margins hold after spin-off - ad-hoc-news.de
Listerine Cool Mint by Kenvue Inc.mouthwash classic fuels recurring sales - ad-hoc-news.de
How Affirmed Talc Successor Liability At Kenvue (KVUE) Has Changed Its Investment Story - simplywall.st
Illinois Municipal Retirement Fund Buys 72,348 Shares of Kenvue Inc. $KVUE - MarketBeat
Kenvue stock trades steadily as consumer health margins stay in focus - ad-hoc-news.de
0.84%
0.18%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):